¤ßÆFªº¥æ¤eÂI: ºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢ (CIDP)
Click Here To more info
¤ßÆFªº¥æ¤eÂI: ºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢ (CIDP)
¥DÃD: ºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢ (CIDP)
½s¿èªÌ ªô Âå®v - 2010/¤C¤ë/12 ¦b 6:18pm
Cho
IP¤w°O¿ý
ªô Âå®v
ºÞ²zû1
µù¥U: 2006/¤Q¤@¤ë/29
ª¬ºA: Â÷½u
µoªí: 4229
µoªí©ó¡J 2010/¤C¤ë/12 ¦b 6:12pm
ºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢ (CIDP)
2009¦~8¤ë8¤é±ß¤W¤EÂI¡A½n¨Ó¤é¥»¥x¼½¥X¡y§Ún·íª¨ª¨ªº¸}¡z¡A ¤s¤fÔG¤H(ªQ¥»¼í¹¢ºt)¹ï¤pºð(»¨½©`¹¢ºt)¤@¨£Á鱡¡A¨â¤H¬ÛÅÊ¡Bµ²±B¡A¨Ã¥Í¤U¤F¥i·Rªº¤k¨à¬ü¦Ð(4 ·³)¡A¤÷¤kÇ¥®É§Î¼v¤£Â÷¡A¤@®a¤T¤f¹LµÛ©¯ºÖªº¥Í¬¡¡C¨S·Q¨ì¡A¯fÅ]«o¬ðµM¨Óŧ¡AÔG¤H¨S¿ìªk¥¿±`¦æ¨«¡A´¤¤O´X¥G®ø¥¢¬pºÉ¡A¬Æ¦Ü³s°_§É³£¦³§xÃø¡AÂå®v¶EÂ_¥L±o¨ì¤F¡u¦NÄõ¤Ú¹p¤ó¯gÔ¸s (GBS)¡v¡C¦NÄõ¤Ú¹p¤ó¯gÔ¸sªº±wªÌ¡A·|¬ðµM¥X²{¥|ªÏµL¤O¡B³Â·ôªº¯gª¬¡A¤@¯ë¦Ó¨¥¡A¬ù 4¶g§Y¥i¦ÛµM³v¨B²¬Â¡¡C¦]¦¹ ÔG¤H©êµÛ«Ü¤jªº´Á±æ¡A²`«H¦Û¤v«Ü§Ö´N¯à«ì´_¥¿±`¡C
µM¦Ó 4Ó§«ô«á¡AÔG¤Hªº¯gª¬«o¤é¯q´c¤Æ¡A¤pºð¤£¶È¹ï¥DªvÂå®v´£¥XºÃ°Ý¡A¤]«ØÄ³´M¨D¨ä¥LÂå¥Íªº·N¨£ ¡Cµ²ªG¸g¹LÂà°|¶EÂ_¡AÂå®v«Å§iÔG¤Hªº¯f¦W¬O¡uºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢ (CIDP) ¡v¡A±w¯f¾÷²v¥u¦³¤Q¸U¤À¤§¤@ªº¨u¨£¯e¯f¡A³oªí¥Ü¡AÔG¤H ¤@¥Í³£µLªk¦A¥¿±`¦æ¨«¤F ... ³o®É±NÔG¤H±qµ´±æªº²`²WùرϥX¨Ó¡A¨ÏÔG¤HÅܱo°í±jªº¬O¡Ð¹ï©d¤l.ºð¡AÁÙ¦³¹ï¤k¨à¬ü¦Ðªº¤@Ó¡y»}¨¥¡z¡C«á¨ÓÔG¤H³z¹Lª`®g§K¬Ì²y³J¥Õ(IVIG)¡AÁöµM¨S¿ìªk§¹¥þ´_ì¤F, ¦ý¬O¥L¹ê²{¤F¥Lµ¹¥L¤k¨àªº¤C¤iÄ@±æ¡Ð¸ò¤k¨àª±Á|°ª°ª¡C¤Wz¤º®eºK¿ý¦Ü½n¨Ó¤é¥»¥xºô¯¸»Pºô¸ô¤å³¹¡C
¤Wºô·j´M¦³Ãö CIDP©Î GBSªº¬ÛÃö¸ê®Æ¨Ã¤£¦h¡A»¡ªk¤]¤£¤Ó¤@¼Ë¡A¡G1. §K¬Ì«¬¯«¸g¯fÅÜ(immune-mediated neuropathy)©ÎºÙ¬°µoª¢«¬¯«¸g¯fÅÜ(inflammatory neuropathy)¬O«ü¦]§K¬Ì¨t²Î²§±`¡A¾ÉP¯«¸g¶b¬ð¡BÅèÀT©Î²ÓM¥»Åé¨ü¶Ë©Ò³y¦¨ªº¯«¸g¯fÅÜ¡C¯U¸qªº§K¬Ì«¬¯«¸g¯fÅܨ̯fµ{¤À¬°«æ©Ê¯«¸g®Úª¢( Guillain-Barre syndrome¡AGBS)»PºC©Ê²æÅèÀT©Ê¯«¸gª¢(chronic inflammatory demyelinating polyneuropathy¡ACIDP)¡C¥»¬qºK¿ý¦Ü¡y°Ñ¦Ò¸ê®Æ¥|¡z¡C
2. ¦³¤@»¡ªk»{¬° CIDP¬O GBSªº¤@ºØ¡A¦]¬° GBS¦³¤À «æ©Êª¢Äp©Ê²æÅèÀT©Ê¦hµo©Ê¯«¸g¯f(acute inflammatory demyelinating polyneu-ropathy¡AAIDP)¤SºÙ Guilain Barreºî¦X©º(GBS)¡BºC©Ê´_µo«¬(CIDP)©MºC©Ê¶i¦æ«¬(CPDP)¡A¦Ó CIDPªº¤¤¤å¦WºÙ¦³¨Ç§Á²§¡C
CIDP¨äÁ{§É¯gª¬¥]¬Aº¥¶i©ÊªÏÅéµL¤O¡A¥]¬AªñºÝ¤Î»·ºÝªº¦Ù¦×¡A¦³®É¤]·|¼vÅT·Pı¯«¸gªº²§±`¡A¨Ò¦p¤â¸}¨ëµh©Î³Â³Âªº·Pı¡A¨äì¦]¬O¦]¬°¦ÛÅé§K¬Ì²ÓM§ðÀ»¦Û¤vªº¯«¸gÅèÀT²ÓM¡A³y¦¨¹B°Ê¤Î·Pı¯«¸g¶Ç¾Éªº²§±`¡C¥»¬qºK¿ý¦Ü¡y°Ñ¦Ò¸ê®Æ¤T¡z¡C
¹ï©ó CIDPªºªvÀø¤è±¡G1. ¦èÂå¡G¦å¼ß¥æ´«¤Î IVIG¨âªÌ¬Ò¥i´î»´¯«¸g¯Ê¥¢¡A¦ý¦]¬° CIDPªº§K¬Ì»Ùê¬O«ùÄò©Êªº¡A¥²»Ý¨Ï¥ÎÃþ©T¾J«O«ùÀø®Ä;¥»¬qºK¿ý¦Ü¡y°Ñ¦Ò¸ê®Æ¥|¡z¡C
2. ¤¤Âå¡Gºô¸ô¤W¨S¦³¬Ý¨ìÃĤè¡A¦ý¡y°Ñ¦Ò¸ê®Æ¤¡z¦³¯f¦]¯fÉ󪺲z½×±´¯Á¡C
¦³¯fn¥h¬ÝÂå¥Í¡A¤£n¦Û¦æ¶ÃªAÃÄ;¤å³¹©Ò´£¨ìªºÃĤè¡BÃħ÷µ¥¡A»Ý¸ß°Ý¤¤Âå®v«á¤~¯à¨Ï¥Î¡A§_«h¥i¯à¦M®`¥Í©R¦w¥þ¡C
°Ñ¦Ò¸ê®Æ¡G¤@¡B Chronic inflammatory demyelinating polyneuropathy
¤G¡B ºC©Ê²æÅèÀT¦hµo©Ê¯«¸gª¢¡G¦Wµü¸ÑÄÀ
¤T¡B ¯«¸g¬ì - e°Ýeµª¡GCIDP
¥|¡B §K¬Ì«¬¯«¸g¯fÅܪº¶EÂ_»PªvÀø
¤¡B ¤¤Âå¹ïºC©Êª¢©Ê²æÅèÀT©Ê¦h¯«¸g¯f¯f¦]¯fÉ󪺲z½×±´¯Á 1. ¢Þ¢Ò¢ÔÀÉ¡A´£¨Ñ¥þ¤å¦b²Ä120¡ã122(©Î ¤å³¹½s¶ 103¡ã105)¶¡C 2. ¢Ô¢Ú¢Ï¢á¢ÖÀÉ¡A¤¤Âå»{¬° CIDPªº¯f¦]¥i°Ñ¦Ò²Ä¤@¶¤¤¢°¡ã¢³ÂIªº±Ôz¡A¨Ã¨S¦³´£¨ÑÃĤè¡C
¤»¡B «æ©Êª¢Äp©Ê²æÅèÀT©Ê¦hµo©Ê¯«¸g¯f
¤C¡B ¤¤Âå¿ëÃÒ¬Iªv¯«¸g¨t²ÎºÃÃø¯f¡G²Åé®ÑÄy¡A°O¿ý¦³Ãö AIDP¯f¯gªº¤¤ÂåªvÀø¤èªk¡C
¤K¡B ¯«¸g¬ì±M¯f¤¤ÂåÁ{§É¶Eªv¡G²Åé®ÑÄy¡A°O¿ý¦³Ãö AIDP¯f¯gªº¤¤¡B¦èÂåªvÀø¤èªk¡C
¤E¡B ²Ó¤ßÂå®v ¶E¥X¨u¨£¯«¸gª¢¡G¬I¦æ¦å¼ß¤ÀÂ÷³N¡A¨Ï¥Î¦å¼ß¤ÀÂ÷¾÷¡A§â±wªÌªº¦å²G¤Þ¬y¥X¡A¤ÀÂ÷¦¨¦å²y»P¦å¼ß¡A§â¦å¼ß¤¤P¯f§ÜÅé¤ÀÂ÷¥X¨Ó¡A¤j¬ù300CC¦å¼ß¡A¾ú¸g5¦¸Àøµ{¡A¯f±w¤w±d´_«ì´_¦æ¨«¡C
2009/10/6·s¼W¡G¤¤¦èÂåµ²¦XªvÀøºC©Ê¦NÄõ¤Ú¹pºî¦X¯g15¨Ò¤ÀªR¡GGBS
2010/2/20¤¤¦èÂåµ²¦XªvÀøºC©Êª¢©Ê²æÅèÀT©Ê¦hµo©Ê¯«¸g®Ú¯«¸g¯f71¨ÒªºÀø®ÄÆ[¹î
Cho
Click Here To more info
keyword: